Bethany Sensenig

Insider Reports History

Location
Raleigh, NC
Signature
/s/ Benjamin L. Palleiko, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bethany Sensenig:

Company Role Class Num Shares Value Price $ Report Date Ownership
SUPERNUS PHARMACEUTICALS, INC. Director Restricted Stock Unit 4,475 $177,658 $39.70 19 Feb 2025 Direct
9 METERS BIOPHARMA, INC. Chief Financial Officer Common stock 41,077 $9,353 $0.2277 21 Apr 2023 Direct
SUPERNUS PHARMACEUTICALS, INC. Director Common Stock 0 $0 $42.25 14 Aug 2025 Direct
SUPERNUS PHARMACEUTICALS, INC. Director Restricted Stock Units 0 $0 $39.70 22 Feb 2025 Direct
KalVista Pharmaceuticals, Inc. Director Stock Option (right to buy) 45,000 01 Oct 2025 Direct
SUPERNUS PHARMACEUTICALS, INC. Director Director Stock Option (Right to Buy) 7,296 19 Feb 2025 Direct

Insider Reports Filed by Bethany Sensenig

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KALV KalVista Pharmaceuticals, Inc. 01 Oct 2025 1 $0 4 Director 02 Oct 2025, 18:28
KALV KalVista Pharmaceuticals, Inc. 01 Oct 2025 0 $0 3 Director 02 Oct 2025, 18:27
SUPN SUPERNUS PHARMACEUTICALS, INC. 14 Aug 2025 1 -$226,840 4 Director 18 Aug 2025, 16:31
SUPN SUPERNUS PHARMACEUTICALS, INC. 22 Feb 2025 2 $0 4 Director 24 Feb 2025, 17:41
SUPN SUPERNUS PHARMACEUTICALS, INC. 19 Feb 2025 2 $0 4 Director 21 Feb 2025, 16:48
SUPN SUPERNUS PHARMACEUTICALS, INC. 22 Feb 2024 2 $0 4 Director 26 Feb 2024, 17:01
SUPN SUPERNUS PHARMACEUTICALS, INC. 17 Aug 2023 1 $0 4 Director 21 Aug 2023, 17:10
SUPN SUPERNUS PHARMACEUTICALS, INC. 17 Aug 2023 0 $0 3 Director 21 Aug 2023, 17:01
/report/000155198623000026-sensenig-bethany-2023-04-21 9 METERS BIOPHARMA, INC. 21 Apr 2023 1 -$11,011 4 Chief Financial Officer 21 Apr 2023, 17:08
/report/000157856323000009-sensenig-bethany-2023-03-27 9 METERS BIOPHARMA, INC. 27 Mar 2023 1 $0 4 Chief Financial Officer 29 Mar 2023, 16:09
/report/000155198622000011-sensenig-bethany-2022-01-18 9 METERS BIOPHARMA, INC. 18 Jan 2022 1 $0 4 Chief Financial Officer 18 Jan 2022, 18:24
/report/000155198622000008-sensenig-bethany-2022-01-17 9 METERS BIOPHARMA, INC. 17 Jan 2022 0 $0 3 Chief Financial Officer 18 Jan 2022, 07:06